GREY MICHAEL G Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$7.19M

Insider Activity of GREY MICHAEL G

According to the SEC Form 4 filings, GREY MICHAEL G, being in a position of

  1. director at Mirum Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 150000 shares for $11.1M,
    over all time since 2023-05-03, has bought 0 shares, and sold 193432 shares for $12.39M.

Biography of GREY MICHAEL G

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$11,100,0003100

Comparison of Insiders on Amount of Buys and Sells

2025-12-19SaleMirum Pharmaceuticals, Inc.
MIRM
director
50,000
0.1016%
$78.00$3.9M+24.31%
2025-12-01SaleMirum Pharmaceuticals, Inc.
MIRM
director
50,000
0.1071%
$74.00$3.7M+37.32%
2025-11-21SaleMirum Pharmaceuticals, Inc.
MIRM
director
50,000
0.0999%
$70.00$3.5M+34.86%
2023-09-14SaleMirum Pharmaceuticals, Inc.
MIRM
director
14,216
0.0367%
$32.00$454,912-10.45%
2023-06-08SaleMirum Pharmaceuticals, Inc.
MIRM
director
14,608
0.0387%
$29.00$423,632-6.64%
2023-05-03SaleMirum Pharmaceuticals, Inc.
MIRM
director
14,608
0.038%
$28.00$409,024-4.62%
2021-03-05SaleBioMarin Pharmaceutical Inc.
BMRN
director
5,000
0.0027%
$76.28$381,400+1.73%
2020-08-03SaleBioMarin Pharmaceutical Inc.
BMRN
director
2,500
0.0014%
$120.35$300,875-35.57%
2016-02-22SaleBioMarin Pharmaceutical Inc.
BMRN
director
15,000
0.007%
$59.30$889,425+10.84%
2015-11-16SaleBioMarin Pharmaceutical Inc.
BMRN
director
15,000
0.0064%
$71.43$1.07M-15.77%
2013-12-11SaleBioMarin Pharmaceutical Inc.
BMRN
director
30,000
0.0214%
$69.66$2.09M+1.57%
2013-03-06SaleBioMarin Pharmaceutical Inc.
BMRN
director
15,000
0.0028%
$14.39$215,850+7.1%
2008-03-05SaleBioMarin Pharmaceutical Inc.
BMRN
director
25,000
0.0255%
$38.23$955,802-28.59%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.